AstraZeneca Plc and Daiichi Sankyo Co.’s cancer drug Enhertu bolstered outcomes for patients with early-stage breast cancer, results that could extend the blockbuster’s reach to tens of thousands more people and move it closer to a potential cure.
from mint - science https://ift.tt/TPqWRX3
Monday, 20 October 2025
AstraZeneca and Daiichi’s drug Enhertu raises hopes for early breast cancer cure
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment